A carregar...
Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis
BACKGROUND: Subcutaneous peginterferon beta-1a every 2 weeks significantly affects clinical outcomes in patients with relapsing–remitting multiple sclerosis (RRMS). OBJECTIVES: To explore relationships between relapses and worsening of disability in patients with RRMS, and assess the treatment effec...
Na minha lista:
| Publicado no: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433498/ https://ncbi.nlm.nih.gov/pubmed/28607743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217316676644 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|